The client is a mid-size biotech organization focused on advancing innovative therapies through clinical research. As trial complexity increased, traditional site-based models created delays in patient recruitment and data collection. To improve speed, accessibility, and data quality, the client aimed to adopt a decentralized clinical trial approach. To enable this transformation, the organization partnered with Zymr.
The client relied heavily on traditional clinical trial models, which limited patient participation due to geographic and logistical constraints. Recruitment timelines were extended, impacting overall study progress and increasing costs.
Data collection processes were fragmented across multiple systems, reducing visibility and consistency. Manual workflows and lack of real-time monitoring affected data accuracy and delayed decision-making.
Additionally, patient engagement was low due to the absence of digital tools for remote participation. The lack of integration between clinical systems such as EDC and CTMS further complicated trial management.
The organization needed a scalable decentralized platform to enable remote patient participation, improve data quality, and accelerate clinical trial timelines.
Zymr enabled the client to transition to a decentralized clinical trial model by implementing a digital platform that improved recruitment, engagement, and data integrity.
Zymr designed and implemented a decentralized clinical trial platform tailored to support remote participation, seamless data flow, and efficient trial management.